Clinical trial
Rosiglitazone Adjunctive Therapy for Severe Malaria in Children
NCT02694874 is registered in ClinicalTrials.gov with Centro de Investigacao em Saude de Manhica as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Rosiglitazone Adjunctive Therapy for Severe Malaria in Children
- Lead sponsor
- Centro de Investigacao em Saude de Manhica
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 29, 2016
- Completion date
- December 31, 2021
- Enrollment
- 210 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.